Terns Pharmaceuticals, Inc.
TERN
$52.63
$0.070.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 11.54% | 10.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.43% | 1.22% | |||
| Operating Income | 0.43% | -1.22% | |||
| Income Before Tax | 5.70% | -2.33% | |||
| Income Tax Expenses | 732.61% | -28.13% | |||
| Earnings from Continuing Operations | 4.32% | -2.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.32% | -2.25% | |||
| EBIT | 0.43% | -1.22% | |||
| EBITDA | 0.43% | -1.21% | |||
| EPS Basic | 10.39% | -2.09% | |||
| Normalized Basic EPS | 11.69% | -2.20% | |||
| EPS Diluted | 10.39% | -2.09% | |||
| Normalized Diluted EPS | 11.69% | -2.20% | |||
| Average Basic Shares Outstanding | 6.77% | 0.14% | |||
| Average Diluted Shares Outstanding | 6.77% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||